Cargando…

Selection of Optimal Cell Lines for High-Content Phenotypic Screening

[Image: see text] High-content microscopy offers a scalable approach to screen against multiple targets in a single pass. Prior work has focused on methods to select “optimal” cellular readouts in microscopy screens. However, methods to select optimal cell line models have garnered much less attenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinrich, Louise, Kumbier, Karl, Li, Li, Altschuler, Steven J., Wu, Lani F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127200/
https://www.ncbi.nlm.nih.gov/pubmed/36920184
http://dx.doi.org/10.1021/acschembio.2c00878
_version_ 1785030413554548736
author Heinrich, Louise
Kumbier, Karl
Li, Li
Altschuler, Steven J.
Wu, Lani F.
author_facet Heinrich, Louise
Kumbier, Karl
Li, Li
Altschuler, Steven J.
Wu, Lani F.
author_sort Heinrich, Louise
collection PubMed
description [Image: see text] High-content microscopy offers a scalable approach to screen against multiple targets in a single pass. Prior work has focused on methods to select “optimal” cellular readouts in microscopy screens. However, methods to select optimal cell line models have garnered much less attention. Here, we provide a roadmap for how to select the cell line or lines that are best suited to identify bioactive compounds and their mechanism of action (MOA). We test our approach on compounds targeting cancer-relevant pathways, ranking cell lines in two tasks: detecting compound activity (“phenoactivity”) and grouping compounds with similar MOA by similar phenotype (“phenosimilarity”). Evaluating six cell lines across 3214 well-annotated compounds, we show that optimal cell line selection depends on both the task of interest (e.g., detecting phenoactivity vs inferring phenosimilarity) and distribution of MOAs within the compound library. Given a task of interest and a set of compounds, we provide a systematic framework for choosing optimal cell line(s). Our framework can be used to reduce the number of cell lines required to identify hits within a compound library and help accelerate the pace of early drug discovery.
format Online
Article
Text
id pubmed-10127200
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101272002023-04-26 Selection of Optimal Cell Lines for High-Content Phenotypic Screening Heinrich, Louise Kumbier, Karl Li, Li Altschuler, Steven J. Wu, Lani F. ACS Chem Biol [Image: see text] High-content microscopy offers a scalable approach to screen against multiple targets in a single pass. Prior work has focused on methods to select “optimal” cellular readouts in microscopy screens. However, methods to select optimal cell line models have garnered much less attention. Here, we provide a roadmap for how to select the cell line or lines that are best suited to identify bioactive compounds and their mechanism of action (MOA). We test our approach on compounds targeting cancer-relevant pathways, ranking cell lines in two tasks: detecting compound activity (“phenoactivity”) and grouping compounds with similar MOA by similar phenotype (“phenosimilarity”). Evaluating six cell lines across 3214 well-annotated compounds, we show that optimal cell line selection depends on both the task of interest (e.g., detecting phenoactivity vs inferring phenosimilarity) and distribution of MOAs within the compound library. Given a task of interest and a set of compounds, we provide a systematic framework for choosing optimal cell line(s). Our framework can be used to reduce the number of cell lines required to identify hits within a compound library and help accelerate the pace of early drug discovery. American Chemical Society 2023-03-15 /pmc/articles/PMC10127200/ /pubmed/36920184 http://dx.doi.org/10.1021/acschembio.2c00878 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Heinrich, Louise
Kumbier, Karl
Li, Li
Altschuler, Steven J.
Wu, Lani F.
Selection of Optimal Cell Lines for High-Content Phenotypic Screening
title Selection of Optimal Cell Lines for High-Content Phenotypic Screening
title_full Selection of Optimal Cell Lines for High-Content Phenotypic Screening
title_fullStr Selection of Optimal Cell Lines for High-Content Phenotypic Screening
title_full_unstemmed Selection of Optimal Cell Lines for High-Content Phenotypic Screening
title_short Selection of Optimal Cell Lines for High-Content Phenotypic Screening
title_sort selection of optimal cell lines for high-content phenotypic screening
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127200/
https://www.ncbi.nlm.nih.gov/pubmed/36920184
http://dx.doi.org/10.1021/acschembio.2c00878
work_keys_str_mv AT heinrichlouise selectionofoptimalcelllinesforhighcontentphenotypicscreening
AT kumbierkarl selectionofoptimalcelllinesforhighcontentphenotypicscreening
AT lili selectionofoptimalcelllinesforhighcontentphenotypicscreening
AT altschulerstevenj selectionofoptimalcelllinesforhighcontentphenotypicscreening
AT wulanif selectionofoptimalcelllinesforhighcontentphenotypicscreening